🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 51 of 78

  1. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8044057

    Methods for suppressing an immune response or treating a proliferative disorder

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8044187

    Human luteinizing hormone superagonists

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8043622

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8029804

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8029809

    Bacteriocins and novel bacterial strains

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8029788

    Variants of humanized anti-carcinoma MAb CC49

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8030287

    DNA vaccine against North American spring viremia of carp virus

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8030341

    Dmt-derivative compounds and related compositions and methods of use

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8025887

    Avirulent, immunogenic flavivirus chimeras

    Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8026350

    Tumor suppressor gene, p28ING5

    Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8022175

    Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8021671

    Pro-apoptotic bacterial vaccines to enhance cellular immune responses

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8017578

    Orally active peptides that prevent cell damage and death

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8017745

    Plasmodium falciparum antigens and methods of use

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8017130

    Method of accelerated vaccination against Ebola viruses

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8012730

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8012493

    Malaria vaccines

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8012699

    Recombinant antigens for diagnosis and prevention of murine typhus

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8012490

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8003764

    Folliculin-specific antibodies and methods of detection

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8003406

    Methods for detecting attention-deficit/hyperactivity disorder

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8003112

    Meningococcal and pneumococcal conjugate vaccine and method of using same

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7999001

    Antiviral compounds and methods of using thereof

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7999071

    Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7999077

    IRTA2 antibodies and methods of use

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7999074

    Bacteriocins and novel bacterial strains

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7999007

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7998682

    Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7993857

    Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7993921

    Cell cycle regulation and differentiation

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7993046

    Flexible light-emitting apparatus

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7993919

    Method of inducing memory B cell development and terminal differentiation

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7988977

    Modified live Aeromonas hydrophila vaccine for aquatic animals

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7988958

    Enterococcus and Streptococcus strains and bacteriocins

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7988971

    Human monoclonal antibodies against Hendra and Nipah viruses

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.